These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37318058)

  • 21. Evaluating infusate parameters for direct drug delivery to the brainstem: a comparative study of convection-enhanced delivery versus osmotic pump delivery.
    Rechberger JS; Power EA; Lu VM; Zhang L; Sarkaria JN; Daniels DJ
    Neurosurg Focus; 2020 Jan; 48(1):E2. PubMed ID: 31896090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The intersect of neurosurgery with diffuse intrinsic pontine glioma.
    Kuzan-Fischer CM; Souweidane MM
    J Neurosurg Pediatr; 2019 Dec; 24(6):611-621. PubMed ID: 31786541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraarterial delivery of bevacizumab and cetuximab utilizing blood-brain barrier disruption in children with high-grade glioma and diffuse intrinsic pontine glioma: results of a phase I trial.
    McCrea HJ; Ivanidze J; O'Connor A; Hersh EH; Boockvar JA; Gobin YP; Knopman J; Greenfield JP
    J Neurosurg Pediatr; 2021 Oct; 28(4):371-379. PubMed ID: 34359048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma.
    El-Khouly FE; Veldhuijzen van Zanten SEM; Jansen MHA; Bakker DP; Sanchez Aliaga E; Hendrikse NH; Vandertop WP; van Vuurden DG; Kaspers GJL
    J Neurooncol; 2021 Jun; 153(2):263-271. PubMed ID: 33963476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma.
    Carceller F; Fowkes LA; Khabra K; Moreno L; Saran F; Burford A; Mackay A; Jones DT; Hovestadt V; Marshall LV; Vaidya S; Mandeville H; Jerome N; Bridges LR; Laxton R; Al-Sarraj S; Pfister SM; Leach MO; Pearson AD; Jones C; Koh DM; Zacharoulis S
    J Neurooncol; 2016 Aug; 129(1):109-21. PubMed ID: 27180091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.
    Hummel TR; Salloum R; Drissi R; Kumar S; Sobo M; Goldman S; Pai A; Leach J; Lane A; Pruitt D; Sutton M; Chow LM; Grimme L; Doughman R; Backus L; Miles L; Stevenson C; Fouladi M; DeWire M
    J Neurooncol; 2016 Mar; 127(1):53-61. PubMed ID: 26626490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infusion-related side-effects during convection enhanced delivery for brainstem-diffuse midline glioma/diffuse intrinsic pontine glioma.
    Hollingworth M; Zacharoulis S
    J Neurooncol; 2022 Sep; 159(2):417-424. PubMed ID: 35933568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-Time, in Vivo Correlation of Molecular Structure with Drug Distribution in the Brain Striatum Following Convection Enhanced Delivery.
    Tosi U; Kommidi H; Bellat V; Marnell CS; Guo H; Adeuyan O; Schweitzer ME; Chen N; Su T; Zhang G; Maachani UB; Pisapia DJ; Law B; Souweidane MM; Ting R
    ACS Chem Neurosci; 2019 May; 10(5):2287-2298. PubMed ID: 30838861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T2-weighted images are superior to other MR image types for the determination of diffuse intrinsic pontine glioma intratumoral heterogeneity.
    Harward S; Harrison Farber S; Malinzak M; Becher O; Thompson EM
    Childs Nerv Syst; 2018 Mar; 34(3):449-455. PubMed ID: 29151166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current status and advances to improving drug delivery in diffuse intrinsic pontine glioma.
    Arms LM; Duchatel RJ; Jackson ER; Sobrinho PG; Dun MD; Hua S
    J Control Release; 2024 Jun; 370():835-865. PubMed ID: 38744345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience.
    Crotty EE; Leary SES; Geyer JR; Olson JM; Millard NE; Sato AA; Ermoian RP; Cole BL; Lockwood CM; Paulson VA; Browd SR; Ellenbogen RG; Hauptman JS; Lee A; Ojemann JG; Vitanza NA
    J Neurooncol; 2020 Jul; 148(3):607-617. PubMed ID: 32556862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma.
    Gállego Pérez-Larraya J; Garcia-Moure M; Labiano S; Patiño-García A; Dobbs J; Gonzalez-Huarriz M; Zalacain M; Marrodan L; Martinez-Velez N; Puigdelloses M; Laspidea V; Astigarraga I; Lopez-Ibor B; Cruz O; Oscoz Lizarbe M; Hervas-Stubbs S; Alkorta-Aranburu G; Tamayo I; Tavira B; Hernandez-Alcoceba R; Jones C; Dharmadhikari G; Ruiz-Moreno C; Stunnenberg H; Hulleman E; van der Lugt J; Idoate MÁ; Diez-Valle R; Esparragosa Vázquez I; Villalba M; de Andrea C; Núñez-Córdoba JM; Ewald B; Robbins J; Fueyo J; Gomez-Manzano C; Lang FF; Tejada S; Alonso MM
    N Engl J Med; 2022 Jun; 386(26):2471-2481. PubMed ID: 35767439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functionalized Macrophage Exosomes with Panobinostat and PPM1D-siRNA for Diffuse Intrinsic Pontine Gliomas Therapy.
    Shan S; Chen J; Sun Y; Wang Y; Xia B; Tan H; Pan C; Gu G; Zhong J; Qing G; Zhang Y; Wang J; Wang Y; Wang Y; Zuo P; Xu C; Li F; Guo W; Xu L; Chen M; Fan Y; Zhang L; Liang XJ
    Adv Sci (Weinh); 2022 Jul; 9(21):e2200353. PubMed ID: 35585670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase I trial of lenalidomide and radiotherapy in children with diffuse intrinsic pontine gliomas or high-grade gliomas.
    Hipp SJ; Goldman S; Kaushal A; Krauze A; Citrin D; Glod J; Walker K; Shih JH; Sethumadhavan H; O'Neill K; Garvin JH; Glade-Bender J; Karajannis MA; Atlas MP; Odabas A; Rodgers LT; Peer CJ; Savage J; Camphausen KA; Packer RJ; Figg WD; Warren KE
    J Neurooncol; 2020 Sep; 149(3):437-445. PubMed ID: 33040274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor dissemination through surgical tracts in diffuse intrinsic pontine glioma.
    Lobon-Iglesias MJ; Santa-Maria Lopez V; Puerta Roldan P; Candela-Cantó S; Ramos-Albiac M; Gomez-Chiari M; Puget S; Bolle S; Goumnerova L; Kieran MW; Cruz O; Grill J; Morales La Madrid A
    J Neurosurg Pediatr; 2018 Dec; 22(6):678-683. PubMed ID: 30192215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a clinical scale for assessment of patients with diffuse intrinsic pontine glioma (DIPG) receiving experimental therapy: the PONScore.
    Hollingworth MA; Zacharoulis S
    J Neurooncol; 2020 Sep; 149(2):263-272. PubMed ID: 32902768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Robot-guided convection-enhanced delivery of carboplatin for advanced brainstem glioma.
    Barua NU; Lowis SP; Woolley M; O'Sullivan S; Harrison R; Gill SS
    Acta Neurochir (Wien); 2013 Aug; 155(8):1459-65. PubMed ID: 23595829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation dose response of neurologic symptoms during conformal radiotherapy for diffuse intrinsic pontine glioma.
    Tinkle CL; Campbell K; Han Y; Li Y; Bianski B; Broniscer A; Khan RB; Merchant TE
    J Neurooncol; 2020 Mar; 147(1):195-203. PubMed ID: 32016716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models.
    Hennika T; Hu G; Olaciregui NG; Barton KL; Ehteda A; Chitranjan A; Chang C; Gifford AJ; Tsoli M; Ziegler DS; Carcaboso AM; Becher OJ
    PLoS One; 2017; 12(1):e0169485. PubMed ID: 28052119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypofractionated radiotherapy in children with diffuse intrinsic pontine glioma.
    Hayashi A; Ito E; Omura M; Aida N; Tanaka M; Tanaka Y; Sato H; Miyagawa N; Yokosuka T; Iwasaki F; Hamanoue S; Goto H
    Pediatr Int; 2020 Jan; 62(1):47-51. PubMed ID: 31785177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.